Literature DB >> 35661063

Preparation of Ricinoleic Acid from Castor Oil:A Review.

Febri Odel Nitbani1, Putra Jiwamurwa Pama Tjitda2, Hermania Em Wogo1, Annytha Ina Rohi Detha3.   

Abstract

Castor oil is a vegetable product extracted from Ricinus communis L (castor seed), which is primarily considered an important commercial value for the manufacturing of soaps, lubricants, coatings, etc. It is rich in hydroxylated fatty acids (ricinoleic acid, 89-92%) and is widely used in the cosmetic, pharmaceutical, oleochemical, and agricultural industries. This oil has also been confirmed as a bactericidal, anti-inflammatory, and antiherpetic agents, due to the ricinoleic acid having functional groups, such as -COOH, -OH, and -C=C-. Furthermore, it is converted into various acid derivative compounds with several applications. Therefore, this article reviewed some reaction stages to the preparation of ricinoleic acid from castor oil. Several methods or reaction pathways were employed in the preparation procedure, such as the Twitchell and Colgate-Emery processes, as well as the alkaline catalyzed, transesterification with methyl ricinoleic, and lipase-catalyzed hydrolysis, respectively. Although each of these preparation methods has advantages and disadvantages, the most effective technique was the hydrolysis through the use of the enzyme lipozyme TL IM. Besides being a green method, the conversion rate in the hydrolysis process was 96.2 ± 1.5.

Entities:  

Keywords:  castrol oil; preparation; ricinoleic acid

Mesh:

Substances:

Year:  2022        PMID: 35661063     DOI: 10.5650/jos.ess21226

Source DB:  PubMed          Journal:  J Oleo Sci        ISSN: 1345-8957            Impact factor:   1.601


  1 in total

1.  Evaluation of Natural and Modified Castor Oil Incorporation on the Melt Processing and Physico-Chemical Properties of Polylactic Acid.

Authors:  Raluca Nicoleta Darie-Niță; Anamaria Irimia; Vasile Cristian Grigoraș; Fănică Mustață; Niță Tudorachi; Maria Râpă; Joanna Ludwiczak; Andrzej Iwanczuk
Journal:  Polymers (Basel)       Date:  2022-09-01       Impact factor: 4.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.